Cargando…
Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations
BACKGROUND: The use of low-dose aspirin has been reported to be associated with an increased risk of upper gastrointestinal complications (UGIC). The coating of aspirin has been proposed as an approach to reduce such a risk. To test this hypothesis, we carried out a population based case-control stu...
Autores principales: | de Abajo, Francisco J, García Rodríguez, Luis A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC32172/ https://www.ncbi.nlm.nih.gov/pubmed/11228592 http://dx.doi.org/10.1186/1472-6904-1-1 |
Ejemplares similares
-
Small Intestinal Perforation Caused by Enteric-coated Low-dose Aspirin
por: Matsubara, Shohei, et al.
Publicado: (2022) -
Bioequivalence of two esomeprazole magnesium enteric-coated formulations in healthy Chinese subjects
por: Liu, Zheng-Zhi, et al.
Publicado: (2020) -
Gastrointestinal symptoms in low-dose aspirin users: a comparison between plain and buffered aspirin
por: Jaspers Focks, J., et al.
Publicado: (2014) -
How soon to start: aspirin resumption after upper gastrointestinal bleed?
por: Gooch, Rebecca, et al.
Publicado: (2010) -
Enteric-Coated Aspirin and the Risk of Gastrointestinal Side Effects: A Systematic Review
por: Kedir, Hanan Muzeyin, et al.
Publicado: (2021)